Showing results (1-10 of 287) with videos related to
Sort By:
Pageof 29
Clinical Pharmacology and Therapeutics|December 1, 1992
Endothelin-I-mediated vasoconstriction: specific blockade by verapamilN S Andrawis, J Gilligan, D R AbernethyThe American Journal of the Medical Sciences|September 1, 1993
Effect of calcium antagonists on RNA synthesis of NIH 3T3 cellsN S Andrawis, D R AbernethyBiochemical and Biophysical Research Communications|March 16, 1992
Verapamil blocks basal and angiotensin II-induced RNA synthesis of rat aortic vascular smooth muscle cellsN S Andrawis, D R AbernethyThe Journal of Pharmacology and Experimental Therapeutics|June 1, 1992
Calcium antagonists block angiotensin II-mediated vasoconstriction in humans: comparison with their effect on phenylephrine-induced vasoconstrictionN S Andrawis, N Craft, D R AbernethyLife Sciences|January 1, 1996
Endothelin-1 induces an increase in total protein synthesis and expression of the smooth muscle alpha-actin gene in vascular smooth muscle cellsN S Andrawis, E Wang, D R AbernethyClinical Pharmacology and Therapeutics|September 1, 1995
Local angiotensin-converting enzyme inhibition blunts endothelin-1-induced increase in forearm vascular resistanceD R Abernethy, N Laurie, N S AndrawisLife Sciences|March 7, 1998
Nitric oxide inhibits Oct-1 DNA binding activity in cultured vascular smooth muscle cellsX K Liu, D R Abernethy, N S AndrawisBiochemical and Biophysical Research Communications|October 29, 1993
Angiotensin II regulates human vascular smooth muscle alpha-actin gene expressionN S Andrawis, E H Ruley, D R AbernethyClinical Pharmacology and Therapeutics|May 1, 1999
Impaired endothelial-dependent forearm vascular relaxation in black AmericansD S Jones, N S Andrawis, D R AbernethyClinical Pharmacology and Therapeutics|January 1, 1994
Verapamil decreases lymphocyte protein kinase C activity in humansP B DePetrillo, D R Abernethy, I W Wainer, et al.Pageof 29